Work

X-linked Adrenoleukodystrophy: Clinical Characteristics, Diagnosis and Management

Year: 2022
Type: article
Abstract: Adrenoleukodystrophy (X-ALD) is a rare X-linked peroxisomal disease, which usually presents in affectedmales with one of three phenotypes: adult-onset adrenomyeloneuropathy (AMN, 45%), childhood-onsetcerebral demyelination (CALD, 35%), or primary adrenal insufficiency (PAI, 10%). Occasionally, X-ALD patientsmay suffer from less specific symptoms resembling those of other neurological conditions. Variabilityin presentation and age of onset can make the diagnosis challenging. AMN should be considered in patientspresenting with spastic paraparesis. Female carriers manifest a late-onset mild form of myelopathyand/or neuropathy. Inclusion of testing for X-ALD in newborn screening programs is expected to expandour understanding of the disorder’s natural history. Newborn screening should enable early detection ofaffected individuals and allow timely therapeutic interventions. Such interventions include corticosteroidreplacement therapy for PAI, allogeneic hematopoietic stem cell transplantation for CALD, and approvedgene therapy (elivaldogene autotemcel) for suitable candidates with childhood CALD. Currently, no effectivetreatment exists for the neurological manifestations of AMN, the commonest presentation of X-ALD.Hopefully, in the near future, novel gene therapy approaches, similar to those recently approved for otherrare neurogenetic diseases may also be developed for X-ALD.
Language: English
Open Access status: diamond
OpenAlex ID: W7220642828
FWCI:
Cites: 71
Cited by:
Related to: 10